Clinical Trials · NCT00206297

The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes

CompletedPhase 3Pramlintide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Baylor College of Medicine
Enrollment
20
Start date
Oct 2003
Locations
1 site, United States
Primary endpoint
Area under the curve for glucose
View Pramlintide compound reference